|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Alphagan P (Brimonidine Ophthalmic). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (8)
Cases resulting in a serious event (5)
Cases resulting in death (1)
Cases resulting in hospitalization (2)
Cases resulting in other serious reactions (2)
Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a individual with unspecified qualification from United States on 2007-10-09
Patient: male, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: Astigmatism, Drug Ineffective, Coma, Photopsia, Diplopia, Vitreous Floaters, Photophobia, Glare, Eye Operation Complication, Depression, Crying, Cataract, Mydriasis, Visual Field Defect, Partner Stress, Social Problem, Loss of Employment, Activities of Daily Living Impaired, Mental Disorder, DRY Eye
Suspect drug(s):
Pilocarpine
Dosage: 4 drops daily occlusive dressing
Indication: Pupillary Disorder
Start date: 2004-10-15
End date: 2007-07-03
Alphagan P
Dosage: 4 drops daily occlusive dressing
Indication: Pupillary Disorder
Start date: 2004-10-15
End date: 2007-10-06
Adverse event in female receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a individual with unspecified qualification from United States on 2007-06-12
Patient: female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Tinnitus, Palpitations, Sensation of Pressure, Feeling Abnormal, Hypertension
Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)
Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from United States on 2007-06-04
Patient: male, weighing 97.5 kg (214.5 pounds)
Adverse reactions / side effects: Blood Creatinine Increased
Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)
Other drugs received by patient: Coumadin; Glucotrol; Lisinopril; Lantus; Bumex; Advair Diskus 100 / 50
Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from United States on 2007-05-08
Patient: male
Adverse reactions / side effects: Renal Failure Acute
Suspect drug(s):
Alphagan P (Brimonidine Ophthalmic)
Other drugs received by patient: Coumadin; Glucotrol; Lisinopril; Lantus; Bumex; Advair Diskus 100 / 50
Adverse event in 86 year old male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from United States on 2007-04-26
Patient: 86 year old male, weighing 68.3 kg (150.3 pounds)
Adverse reactions / side effects: Pupillary Reflex Impaired, Eye Irritation, Visual Field Defect, Corneal Scar, Documented Hypersensitivity TO Administered Drug, Drug Hypersensitivity, Ocular Hyperaemia
Suspect drug(s):
Alphagan P
Dosage: 1 drop ou q 8 hours
Indication: Glaucoma
Start date: 2006-09-22
End date: 2006-12-12
Alphagan
Dosage: 1 drop ou q 12 hours
Indication: Glaucoma
Start date: 2001-09-03
End date: 2002-09-12
Other drugs received by patient: Cosopt; Travatan; Aspirin; Terazosin HCL; Simvastatin; Levalbuterol Tart; Ipratropium BR; Flunisolide; Colchicine; Brimonidine Tartrate; Meclizine
Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from Korea, Republic of on 2007-02-14
Patient: 26 year old female
Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Retinal Disorder, Optic Nerve CUP / Disc Ratio Increased, Condition Aggravated, Visual Acuity Reduced, Corneal Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Cosopt
Dosage: unk opht
Indication: Developmental Glaucoma
Cosopt
Dosage: unk opht
Indication: Open Angle Glaucoma
Alphagan P
Dosage: unk opht
Indication: Developmental Glaucoma
Alphagan P
Dosage: unk opht
Indication: Open Angle Glaucoma
Xalatan
Dosage: unk opht
Indication: Developmental Glaucoma
Xalatan
Dosage: unk opht
Indication: Open Angle Glaucoma
Adverse event in 85 year old female receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from United States on 2007-02-07
Patient: 85 year old female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Alphagan P
Dosage: unk, bid
Indication: Glaucoma
Start date: 2006-10-06
End date: 2007-01-22
Lumigan
Indication: Glaucoma
Start date: 2006-10-06
End date: 2007-01-22
Adverse event in 26 year old female receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from Korea, Republic of on 2007-02-06
Patient: 26 year old female
Adverse reactions / side effects: Drug Ineffective, Intraocular Pressure Increased, Vision Blurred, Visual Acuity Reduced, Corneal Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Cosopt
Dosage: opht
Indication: Developmental Glaucoma
Cosopt
Dosage: opht
Indication: Open Angle Glaucoma
Alphagan P
Dosage: opht
Indication: Developmental Glaucoma
Alphagan P
Dosage: opht
Indication: Open Angle Glaucoma
Xalatan
Dosage: opht
Indication: Developmental Glaucoma
Xalatan
Dosage: opht
Indication: Open Angle Glaucoma
|
